Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -57.95% is 13% above its 5-year average of -66.64%, around the middle of its 5-year range (-207.50%–22.71%).
1312.34% below its 12-month average of 4.78%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -18.38%.
RETURN ON ASSETS (ROA)
-57.95%
RETURN ON ASSETS (ROA) AVG TTM
4.78%
RETURN ON ASSETS (ROA) AVG 3Y
-64.05%
RETURN ON ASSETS (ROA) AVG 5Y
-66.64%
RETURN ON ASSETS (ROA) AVG 10Y
-98.26%
RETURN ON ASSETS (ROA) AVG 15Y
-100.88%
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-1312.34%
CURRENT VS 3Y AVG
+9.52%
CURRENT VS 5Y AVG
+13.04%
CURRENT VS 10Y AVG
+41.02%
CURRENT VS 15Y AVG
+42.56%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.77%
median of 814 covered companies
CURRENT VS SECTOR MEDIAN
-82.40%
vs the sector median at left
BioStem Technologies, Inc.
Market Cap
$43.73M
Return on Assets (ROA)
-57.95%
TTM Avg
4.78%
3Y Avg
-64.05%
5Y Avg
-66.64%
Market Cap
$43.17M
Return on Assets (ROA)
39.10%
TTM Avg
-36.27%
3Y Avg
-59.86%
5Y Avg
-86.70%
Market Cap
$41.93M
Return on Assets (ROA)
-5.70%
TTM Avg
-13.47%
3Y Avg
-29.01%
5Y Avg
-32.57%
Market Cap
$43.69M
Return on Assets (ROA)
-128.10%
TTM Avg
-35.87%
3Y Avg
-35.25%
5Y Avg
-29.40%
Market Cap
$43.87M
Return on Assets (ROA)
-87.60%
TTM Avg
-55.36%
3Y Avg
-44.79%
5Y Avg
-43.77%
Market Cap
$44.21M
Return on Assets (ROA)
-56.31%
TTM Avg
-47.91%
3Y Avg
-41.18%
5Y Avg
-35.79%
Market Cap
$44.82M
Return on Assets (ROA)
70.17%
TTM Avg
-36.93%
3Y Avg
-46.92%
5Y Avg
-57.84%
Market Cap
$40.42M
Return on Assets (ROA)
-40.69%
TTM Avg
-38.43%
3Y Avg
-19.21%
5Y Avg
-15.37%
Market Cap
$45.20M
Return on Assets (ROA)
-143.30%
TTM Avg
-71.59%
3Y Avg
-49.53%
5Y Avg
-40.25%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | $43.73M | -57.95% | 4.78% | -64.05% | -66.64% |
| SANUWAVE Health Inc. (SNWV)vs › | $43.17M | 39.10% | -36.27% | -59.86% | -86.70% |
| Precipio, Inc. (PRPO)vs › | $41.93M | -5.70% | -13.47% | -29.01% | -32.57% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.69M | -128.10% | -35.87% | -35.25% | -29.40% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.87M | -87.60% | -55.36% | -44.79% | -43.77% |
| CVRx, Inc. (CVRX)vs › | $44.21M | -56.31% | -47.91% | -41.18% | -35.79% |
| DarioHealth Corp. (DRIO)vs › | $44.82M | 70.17% | -36.93% | -46.92% | -57.84% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.42M | -40.69% | -38.43% | -19.21% | -15.37% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | -143.30% | -71.59% | -49.53% | -40.25% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.53M | -53.81% | -31.90% | -23.26% | -21.62% |
ROA
-58.0%
ROE
-102.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -13.15% |
| 2024-12-31 | 22.71% |
| 2023-12-31 | -58.26% |
| 2022-12-31 | -207.50% |
| 2021-12-31 | -54.10% |
| 2020-12-31 | -89.54% |
| 2019-12-31 | -202.39% |
| 2018-12-31 | -176.62% |
| 2017-12-31 | -159.62% |
| 2016-12-31 | -61.29% |
| 2015-12-31 | -81.06% |
| 2014-12-31 | -166.06% |
| 2013-12-31 | -242.31% |
| 2012-12-31 | -893.27% |
| 2011-12-31 | -15.17% |
| 2010-12-31 | -8.84% |
